TWD 14.35
(-22.85%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | 69.14 Million TWD | 228.14% |
2022 | -53.95 Million TWD | 16.1% |
2021 | -64.31 Million TWD | -703.58% |
2020 | 10.65 Million TWD | 108.82% |
2019 | -119.65 Million TWD | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q2 | 4.43 Million TWD | -32.06% |
2024 Q1 | 6.52 Million TWD | -67.77% |
2023 Q1 | 421 Thousand TWD | 104.98% |
2023 Q3 | 20.25 Million TWD | 4710.21% |
2023 FY | - TWD | 228.14% |
2023 Q4 | 20.25 Million TWD | 0.0% |
2023 Q2 | 421 Thousand TWD | 0.0% |
2022 Q3 | -8.45 Million TWD | 0.0% |
2022 FY | - TWD | 16.1% |
2022 Q4 | -8.45 Million TWD | 0.0% |
2021 FY | - TWD | -703.58% |
2020 FY | - TWD | 108.82% |
2019 FY | - TWD | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Anti-Microbial Savior BioteQ Co., Ltd | -46.24 Million TWD | 249.518% |
SYN-TECH Chem. & Pharm. Co., Ltd. | 393.6 Million TWD | 82.433% |
Level Biotechnology Inc. | 98.7 Million TWD | 29.949% |
Sagittarius Life Science Corp | -44.73 Million TWD | 254.547% |
NeoCore Technology Co., Ltd. | -72.11 Million TWD | 195.879% |
TaiMed Biologics Inc. | -25.23 Million TWD | 374.018% |
GlycoNex Incorporation | -126.82 Million TWD | 154.518% |
VBI | -6.97 Million TWD | 1091.724% |
GeneReach Biotechnology Corp. | -143.69 Million TWD | 148.118% |
Taiwan Advance Bio-Pharmaceutical Inc. | 21.81 Million TWD | -217.024% |
SynCore Biotechnology Co.,Ltd | -17.72 Million TWD | 490.065% |
Genomics BioSci & Tech. Co.,Ltd. | -103.61 Million TWD | 166.731% |
Visgeneer Inc. | 973 Thousand TWD | -7006.166% |
Mycenax Biotech Inc. | -339.48 Million TWD | 120.367% |
Sunmax Biotechnology Co., Ltd. | 936.46 Million TWD | 92.617% |
G&E Herbal Biotechnology Co., Ltd. | 99.83 Million TWD | 30.744% |
Neith Corporation | -33.61 Million TWD | 305.722% |
Medigen Vaccine Biologics Corporation | -991.09 Million TWD | 106.976% |
TaiwanJ Pharmaceuticals Co., Ltd. | -1.73 Million TWD | 4080.599% |
Enimmune corporation | -228.96 Million TWD | 130.198% |
TaiRx, Inc. | -208.64 Million TWD | 133.139% |
CHO Pharma, Inc. | -277.73 Million TWD | 124.896% |
EirGenix Inc. | -664.4 Million TWD | 110.407% |
BioLASCO Taiwan Co., Ltd. | 73.9 Million TWD | 6.442% |
Lin BioScience, Inc. | -1.07 Billion TWD | 106.454% |
BioGend Therapeutics Co., Ltd. | -113.1 Million TWD | 161.131% |
Feng Chi Biotech Corp. | 34.83 Million TWD | -98.47% |
Bio Preventive Medicine Corp. | -62.34 Million TWD | 210.911% |
Lukas Biomedical Inc. | -26.3 Million TWD | 362.901% |
RBC Bioscience Corporation | 36.54 Million TWD | -89.189% |
BiOptic Inc. | 65.03 Million TWD | -6.312% |
BRIM Biotechnology, Inc. | -682.46 Million TWD | 110.131% |
Shine-On BioMedical Co.,Ltd. | -33 Million TWD | 309.486% |
Great Novel Therapeutics Biotech & Medicals | -54.91 Million TWD | 225.909% |
Syngen Biotech Co.,Ltd. | 433.55 Million TWD | 84.052% |
Advagene Biopharma Co., Ltd. | -80.07 Million TWD | 186.351% |
NaviFUS Corp. | -55.79 Million TWD | 223.923% |
Gwo Xi Stem Cell Applied Technology Co. , Ltd | -16.59 Million TWD | 516.574% |
Sinew Pharma Inc. | -163.63 Million TWD | 142.255% |
Andros Pharmaceuticals Co.,Ltd | -61.5 Million TWD | 212.428% |
Greenyn Biotechnology Co., Ltd | 192.4 Million TWD | 64.063% |
Lumosa Therapeutics Co., Ltd. | -226.67 Million TWD | 130.503% |
AP Biosciences Inc | -325.51 Million TWD | 121.241% |
Medigen Biotechnology Corp. | -1.04 Billion TWD | 106.619% |
3D Global Biotech Inc. | -35.84 Million TWD | 292.889% |
Pharmosa Biopharm Inc. | 29.13 Million TWD | -137.36% |
Intech Biopharm Corporation | -219.58 Million TWD | 131.488% |
Oneness Biotech Co., Ltd. | -674.22 Million TWD | 110.255% |
Eusol Biotech Co.,Ltd. | -44.95 Million TWD | 253.819% |
TWi Biotechnology, Inc. | -160.85 Million TWD | 142.984% |
Ever Supreme Bio Technology Co., Ltd | 655.52 Million TWD | 89.452% |
TCI GENE Inc. | 25.98 Million TWD | -166.129% |
MegaPro Biomedical Co., Ltd | -110.63 Million TWD | 162.495% |
Senhwa Biosciences, Inc. | -283.78 Million TWD | 124.365% |
Taiwan Bio Therapeutics Co., Ltd | -145.97 Million TWD | 147.368% |
NatureWise Biotech & Medicals Corporation | 13.85 Million TWD | -399.227% |
PharmaEngine, Inc. | 347.3 Million TWD | 80.092% |
Savior Lifetec Corporation | 219.6 Million TWD | 68.515% |
TaiGen Biopharmaceuticals Holdings Limited | 172.23 Million TWD | 59.854% |
OBI Pharma, Inc. | -855.08 Million TWD | 108.086% |
Meribank Biotech Co., Ltd | -92.56 Million TWD | 174.698% |
Acepodia, Inc. | -764.51 Million TWD | 109.044% |
Caliway Biopharmaceuticals Co., Ltd. | -460.09 Million TWD | 115.028% |